Open AccessSafety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer
Author(s) -
Dan Pu,
Liyuan Yin,
Yaqi Zhou,
Li Ming Wen,
Hailong Lin,
Liang Cai,
Qinghua Zhou
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000019013
Subject(s) - medicine , atezolizumab , nivolumab , tremelimumab , durvalumab , pembrolizumab , ipilimumab , hepatitis c virus , hepatitis b virus , hepatitis c , hbsag , adverse effect , cancer , hepatitis b , immunology , oncology , immunotherapy , virus